Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
University of Washington
Seattle, Estados UnidosPublications en collaboration avec des chercheurs de University of Washington (5)
2015
-
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes
Nature Communications, Vol. 6
2012
-
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
Journal of Cellular Physiology, Vol. 227, Núm. 4, pp. 1319-1325
2011
-
The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells
Journal of Cellular Physiology, Vol. 226, Núm. 5, pp. 1214-1223
-
The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanisms
Biochemical Pharmacology, Vol. 82, Núm. 11, pp. 1583-1592
2008
-
Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity
Journal of Hepatology, Vol. 49, Núm. 6, pp. 965-976